Arstasis Announces Key Thought Leaders In Cardiology And Vascular Interventions To Join Company's Scientific Advisory Board
FREMONT, Calif., Nov. 5, 2014 /PRNewswire/ -- Arstasis, the Silicon Valley based developer and manufacturer of medical devices, announced today the formation of their Scientific Advisory Board.
This distinguished group of leading experts will bring a wealth of clinical expertise, device development experience, and hospital based operational insight that will support the on-going growth initiatives of Arstasis.
The newly appointed board will contribute to the company's continued research and development efforts, as well as provide strategic guidance as Arstasis develops products and services to support physicians, clinical staff, and their patients.
The prominent members of the Scientific Advisory Board include the following:
Samir Germanwala, D.O. Interventional Cardiologist | Steve Ramee, M.D. |
Jaafer Golzar, M.D. | Greg Sampognaro |
Venkatesh Ramaiah, M.D. | Richard Schatz, M.D. |
The AXERA® Access Device is a novel vascular access device producing accelerated compression times and ambulation eliminating the need for vascular closure devices and associated use of foreign body implants. Over 60,000 successful AXERA cases have been performed in the United States.
For information about the AXERA® Access Device, please visit www.arstasis.com
Media Contact
Sona Donovan
650.261.8047
SDonovan@arstasis.com
SOURCE Arstasis